Repositioning Candidate Details
| Candidate ID: | R0421 |
| Source ID: | DB04455 |
| Source Type: | experimental; investigational |
| Compound Type: | small molecule |
| Compound Name: | N,N,N-trimethylglycinium |
| Synonyms: | |
| Molecular Formula: | C5H12NO2 |
| SMILES: | C[N+](C)(C)CC(O)=O |
| Structure: |
|
| DrugBank Description: | A naturally occurring compound that has been of interest for its role in osmoregulation. As a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. Betaine has also been used in the treatment of liver disorders, for hyperkalemia, for homocystinuria, and for gastrointestinal disturbances. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1341) |
| CAS Number: | |
| Molecular Weight: | 118.1543 |
| DrugBank Indication: | |
| DrugBank Pharmacology: | |
| DrugBank MoA: | |
| Targets: | Circadian clock protein KaiB; Glycine betaine-binding periplasmic protein |
| Inclusion Criteria: |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class |
|---|